[Skip navigation]FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
 HHS Logo links to Department of Health and Human Services website
Drugs at FDA: FDA Approved Drug Products. Links to Initial Search Page FAQ  |  Instructions  |  Glossary  |  Contact Us  |  CDER Home 
Start Over (Drugs@FDA Home)

Drug Details
Drug Name(s) METAGLIP (Brand Name Drug)
FDA Application No. (NDA) 021460
Active Ingredient(s) GLIPIZIDE; METFORMIN HYDROCHLORIDE
Company BRISTOL MYERS SQUIBB
Original Approval or Tentative Approval Date October 21, 2002
Chemical Type 4  New combination
Review Classification S  Standard review drug  


Products on Application (NDA) #021460
    Click on a column header to re-sort the table:

Drug Name
Active Ingredients
Strength
Dosage Form/Route
Marketing
Status
RLD
TE
Code
METAGLIP  GLIPIZIDE; METFORMIN HYDROCHLORIDE  2.5MG; 250MG  TABLET; ORAL  Prescription  No AB  
METAGLIP  GLIPIZIDE; METFORMIN HYDROCHLORIDE  2.5MG; 500MG  TABLET; ORAL  Prescription  No AB  
METAGLIP  GLIPIZIDE; METFORMIN HYDROCHLORIDE  5MG; 500MG  TABLET; ORAL  Prescription  Yes AB  

Back to Top | Back to Previous Page | Back to Drugs@FDA Home

Disclaimer
CDER Home Page | Contact CDER | What's New @ CDER
FDA Home Page | FDA A-Z Index | Contact FDA | Privacy | Accessibility | HHS Home Page
FDA/Center for Drug Evaluation and Research
Office of Training and Communications
Division of Information Services
Update Frequency: Daily